Member States should also take steps to guarantee access to appropriate services to prevent the propagation of HIV/AIDS, hepatitis C and other blood-borne infectious diseases, as well as to reduce the number of deaths caused by drugs.

First, serological or blood testing is conducted to determine the presence of infectious disease such as hepatitis B, hepatitis C, human T cell lymphotropic virus types I or II, Epstein Barr virus, cytomegalovirus, or human immunodeficiency virus HIV the virus that causes AIDS.

the increased risk of spreading HIV, hepatitis and other infectious diseases through untreated injecting drug users to other drug users and the general population;

- health: health of key population groups; major diseases and disorders (e.g. cancer, diabetes and diabetes-related diseases, degenerative diseases of the nervous system, psychiatric diseases, cardiovascular diseases, hepatitis, allergies, visual impairment, infectious diseases), rare diseases; alternative or non-conventional medicine; and major diseases linked to poverty in developing countries; palliative care; activities involved will be implemented, for instance, through coordination of research and comparative studies, development of European databases and interdisc ...[+++]iplinary networks, exchange of clinical practice and coordination of clinical trials.

With regard to the specific wording of Bill C-217, the IAFF proposes that the term “designated virus” be changed to “designated infectious diseases” in order to specifically include infectious pulmonary tuberculosis, hepatitis B, hepatitis C, HIV/AIDS, diphtheria, hemorrhagic fevers, meningococcal disease, plague, and rabies.

That doesn't sound like anything that's very great, but at the moment one of our infectious disease scourges is hepatitis C. We have no model for hepatitis C no way to measure vaccines or to measure treatments, short of going to people or primates, and primates are prohibitively expensive.